W.O. Böcher

481 total citations
17 papers, 374 citations indexed

About

W.O. Böcher is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, W.O. Böcher has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in W.O. Böcher's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (6 papers) and Immunotherapy and Immune Responses (5 papers). W.O. Böcher is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (6 papers) and Immunotherapy and Immune Responses (5 papers). W.O. Böcher collaborates with scholars based in Germany, United States and France. W.O. Böcher's co-authors include H Löhr, Sabine Herzog‐Hauff, Guido Gerken, Ansgar W. Lohse, Karl‐Hermann Meyer zum Büschenfelde, Peter R. Galle, JF Schlaak, W. Herr, K.‐H. Heermann and Tarik Asselah and has published in prestigious journals such as Hepatology, Journal of Hepatology and Clinical & Experimental Immunology.

In The Last Decade

W.O. Böcher

15 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.O. Böcher Germany 8 315 279 110 51 46 17 374
J Fehr Germany 3 280 0.9× 359 1.3× 87 0.8× 21 0.4× 60 1.3× 6 384
T. Gerlach Germany 6 186 0.6× 241 0.9× 75 0.7× 17 0.3× 35 0.8× 12 304
J. H. Hoofnagle United States 11 295 0.9× 275 1.0× 38 0.3× 64 1.3× 61 1.3× 14 414
Bharati Pai 7 198 0.6× 247 0.9× 81 0.7× 77 1.5× 47 1.0× 8 388
Koju Kobayashi Japan 11 206 0.7× 209 0.7× 85 0.8× 22 0.4× 23 0.5× 22 318
Nobutoshi Komatsu Japan 9 166 0.5× 201 0.7× 45 0.4× 30 0.6× 26 0.6× 19 252
Arleta Kowala‐Piaskowska Poland 12 203 0.6× 220 0.8× 109 1.0× 52 1.0× 16 0.3× 56 376
Antoaneta A. Markova Germany 9 306 1.0× 442 1.6× 103 0.9× 129 2.5× 18 0.4× 16 509
Zehui Yan China 11 253 0.8× 237 0.8× 64 0.6× 22 0.4× 17 0.4× 18 354
Shigehiko Sainokami Japan 7 259 0.8× 344 1.2× 24 0.2× 52 1.0× 74 1.6× 9 379

Countries citing papers authored by W.O. Böcher

Since Specialization
Citations

This map shows the geographic impact of W.O. Böcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.O. Böcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.O. Böcher more than expected).

Fields of papers citing papers by W.O. Böcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.O. Böcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.O. Böcher. The network helps show where W.O. Böcher may publish in the future.

Co-authorship network of co-authors of W.O. Böcher

This figure shows the co-authorship network connecting the top 25 collaborators of W.O. Böcher. A scholar is included among the top collaborators of W.O. Böcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.O. Böcher. W.O. Böcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2013). 1227 AN ANALYSIS OF RESPONSE RATES BY FIBROSIS STAGE IN PATIENTS TREATED WITH FALDAPREVIR, BI 207127 AND RIBAVIRIN IN THE SOUND-C2 STUDY. Journal of Hepatology. 58. S498–S498. 1 indexed citations
2.
Asselah, Tarik, S Zeuzem, Vincent Soriano, et al.. (2013). 1186 ITPA GENE VARIANTS PREDICT HEMOLYTIC RIBAVIRIN INDUCED ANAEMIA IN PATIENTS TREATED WITH THE INTERFERON-FREE REGIMEN OF FALDAPREVIR, BI 207127 AND RIBAVIRIN IN SOUND-C2. Journal of Hepatology. 58. S482–S482. 3 indexed citations
3.
Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2012). 101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2. Journal of Hepatology. 56. S45–S45. 53 indexed citations
4.
Kukolj, George, Richard C. Bethell, Mariano Cartier, et al.. (2012). 1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS. Journal of Hepatology. 56. S469–S469. 4 indexed citations
5.
Sulkowski, Mark, Marc Bourlière, J.‐P. Bronowicki, et al.. (2011). 66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R. Journal of Hepatology. 54. S30–S30. 25 indexed citations
7.
Sulkowski, Mark, Tarik Asselah, Florin Alexandru Căruntu, et al.. (2011). 60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION. Journal of Hepatology. 54. S27–S27. 28 indexed citations
8.
Chung, Lip Yong, Joseph Schérer, John P. Sabo, et al.. (2011). 1249 BI201335 PHARMACOKINETICS AND EARLY EFFECT ON VIRAL LOAD IN HCV GENOTYPE-1 PATIENTS. Journal of Hepatology. 54. S493–S493. 2 indexed citations
9.
Herzog‐Hauff, Sabine, et al.. (2007). Vaccination with dendritic cells induces strong HBV specific Th cell and CTL responses in HBV trimera mice. Zeitschrift für Gastroenterologie. 45(1).
10.
Mederacke, Ingmar, Sabine Herzog‐Hauff, Dieter Glebe, et al.. (2007). Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clinical & Experimental Immunology. 151(1). 61–70. 53 indexed citations
11.
Heintges, Tobias, Dieter Häussinger, W.O. Böcher, et al.. (2006). Hepatitis B.
12.
Krüger, Anke, Juergen Hammer, W.O. Böcher, et al.. (2005). Hepatitis B surface antigen presentation and HLA-DRB1*– lessons from twins and peptide binding studies. Clinical & Experimental Immunology. 140(2). 325–332. 26 indexed citations
13.
Löhr, H, Sabine Pingel, W.O. Böcher, et al.. (2002). Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12. Clinical & Experimental Immunology. 130(1). 107–114. 40 indexed citations
14.
Löhr, H, JF Schlaak, Ansgar W. Lohse, et al.. (1996). Autoreactive Cd4+ Lkm–Specific and Anticlonotypic T–Cell Responses in Lkm–1 Antibody–Positive Autoimmune Hepatitis. Hepatology. 24(6). 1416–1421. 75 indexed citations
15.
Böcher, W.O., Sabine Herzog‐Hauff, W. Herr, et al.. (1996). Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clinical & Experimental Immunology. 105(1). 52–58. 55 indexed citations
16.
Böcher, W.O., Peter Schirmacher, H Löhr, et al.. (1995). Hepatic manifestation of hemolytic uremic syndrome in an allogeneic bone marrow transplant recipient.. PubMed. 33(9). 543–5. 2 indexed citations
17.
Löhr, H, W.O. Böcher, E Hermann, et al.. (1994). Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.. PubMed. 52(5). 307–11. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026